
While breast cancer imaging guidelines recommend annual screening for five years after treatment for ductal carcinoma in situ (DCIS), a new study of over 12,000 women found that only 52 percent had consistent surveillance screening with researchers noting disproportionately lower follow-up imaging rates for Black and Hispanic women.





























